MucoUp® as a spacer in brachytherapy for uterine cervical cancer: A first-in-human experience

We first used MucoUp®, a hyaluronic acid used in endoscopic resection, as a spacer in brachytherapy. In five cervical cancer patients, MucoUp® insertion increased a 90% dose of the high-risk CTV to over 80 Gy while decreasing the dose of organs at risk. No related adverse events were observed.

Detalles Bibliográficos
Autores principales: Muramoto, Yoichi, Murakami, Naoya, Karino, Tatsuki, Sugimoto, Satoru, Takatsu, Jun, Oshima, Masaki, Kosugi, Yasuo, Kawamoto, Terufumi, Hirayama, Takashi, Fujino, Kazunari, Terao, Yasuhisa, Shikama, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372547/
https://www.ncbi.nlm.nih.gov/pubmed/37519921
http://dx.doi.org/10.1016/j.ctro.2023.100659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372547/
https://www.ncbi.nlm.nih.gov/pubmed/37519921
http://dx.doi.org/10.1016/j.ctro.2023.100659

Ejemplares similares